Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma

por Kang, Qiang, Zou, Hao, Yang, Xuan, Cai, Jia-Bin, Liu, Li-Xin, Xie, Nan, Wang, Lian-Min, Li, Yue-Hua, Zhang, Xiao-Wen
Publicado 2018

Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma

por Zhang, Peng-Fei, Gao, Chao, Huang, Xiao-Yong, Lu, Jia-Cheng, Guo, Xiao-Jun, Shi, Guo-Ming, Cai, Jia-Bin, Ke, Ai-Wu
Publicado 2020

The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma

por Huang, Jian-Hang, Wang, Jie, Chai, Xiao-Qiang, Li, Zhong-Chen, Jiang, Ying-Hua, Li, Jun, Liu, Xing, Fan, Jia, Cai, Jia-Bin, Liu, Feng
Publicado 2022

Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients

por Huang, Xiao-Yong, Zhang, Chi, Cai, Jia-Bin, Shi, Guo-Ming, Ke, Ai-Wu, Dong, Zhao-Ru, Zhang, Peng-Fei, Fan, Jia, Peng, Bao-Gang, Zhou, Jian
Publicado 2014

Predicting overall survival of patients with hepatocellular carcinoma using a three‐category method based on DNA methylation and machine learning

por Dong, Rui‐Zhao, Yang, Xuan, Zhang, Xin‐Yu, Gao, Ping‐Ting, Ke, Ai‐Wu, Sun, Hui‐chuan, Zhou, Jian, Fan, Jia, Cai, Jia‐bin, Shi, Guo‐Ming
Publicado 2019

Neoadjuvant transcatheter arterial chemoembolization and systemic chemotherapy for the treatment of undifferentiated embryonal sarcoma of the liver in children

por He, Min, Cai, Jia-Bin, Lai, Can, Mao, Jun-Qing, Xiong, Jie-Ni, Guan, Zhong-Hai, Li, Lin-Jie, Shu, Qiang, Ying, Mei-Dan, Wang, Jin-Hu
Publicado 2022

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

por Wang, Si-Wei, Gao, Chao, Zheng, Yi-Min, Yi, Li, Lu, Jia-Cheng, Huang, Xiao-Yong, Cai, Jia-Bin, Zhang, Peng-Fei, Cui, Yue-Hong, Ke, Ai-Wu
Publicado 2022

Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis

por Dong, Zhao-Ru, Zou, Jie, Sun, Dong, Shi, Guo-Ming, Ke, Ai-Wu, Cai, Jia-Bin, Sun, Hui-Chuan, Qiu, Shuang-Jian, Li, Tao, Zhou, Jian, Zhi, Xu-Ting, Fan, Jia
Publicado 2017

The long noncoding RNA NORAD enhances the TGF‐β pathway to promote hepatocellular carcinoma progression by targeting miR‐202‐5p

por Yang, Xuan, Cai, Jia‐Bin, Peng, Rui, Wei, Chuan‐Yuan, Lu, Jia‐Cheng, Gao, Chao, Shen, Zhao‐Zuo, Zhang, Peng‐Fei, Huang, Xiao‐Yong, Ke, Ai‐Wu, Shi, Guo‐Ming, Fan, Jia
Publicado 2018

UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2

por Bai, Dou-Sheng, Wu, Chao, Yang, Liu-Xiao, Zhang, Chi, Zhang, Peng-Fei, He, Yi-Zhou, Cai, Jia-Bin, Song, Zheng-Ji, Dong, Zhao-Ru, Huang, Xiao-Yong, Ke, Ai-Wu, Shi, Guo-Ming
Publicado 2016

NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells

por Hu, Bo, Ding, Guang-Yu, Fu, Pei-Yao, Zhu, Xiao-Dong, Ji, Yuan, Shi, Guo-Ming, Shen, Ying-Hao, Cai, Jia-Bin, Yang, Zhen, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan, Kuang, Ming, Huang, Cheng
Publicado 2018

Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma

por Peng, Rui, Zhang, Peng-Fei, Yang, Xuan, Wei, Chuan-Yuan, Huang, Xiao-Yong, Cai, Jia-Bin, Lu, Jia-Cheng, Gao, Chao, Sun, Hai-Xiang, Gao, Qiang, Bai, Dou-Sheng, Shi, Guo-Ming, Ke, Ai-Wu, Fan, Jia
Publicado 2019

Circular RNA circTRIM33–12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression

por Zhang, Peng-Fei, Wei, Chuan-Yuan, Huang, Xiao-Yong, Peng, Rui, Yang, Xuan, Lu, Jia-Cheng, Zhang, Chi, Gao, Chao, Cai, Jia-Bin, Gao, Ping-Ting, Gao, Dong-Mei, Shi, Guo-Ming, Ke, Ai-Wu, Fan, Jia
Publicado 2019

KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma

por Gao, Chao, Wang, Si-wei, Lu, Jia-cheng, Chai, Xiao-qiang, Li, Yuan-cheng, Zhang, Peng-fei, Huang, Xiao-yong, Cai, Jia-bin, Zheng, Yi-min, Guo, Xiao-jun, Shi, Guo-ming, Ke, Ai-wu, Fan, Jia
Publicado 2022

Lymphoid‐specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression

por Yang, Xuan, Miao, Bi‐Si, Wei, Chuan‐Yuan, Dong, Rui‐Zhao, Gao, Ping‐Ting, Zhang, Xin‐Yu, Lu, Jia‐Cheng, Gao, Chao, Wang, Xiao‐Ying, Sun, Hui‐Chuan, Zhou, Jian, Fan, Jia, Ke, Ai‐Wu, Shi, Guo‐Ming, Cai, Jia‐Bin
Publicado 2019

Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma

por Lu, Jia-Cheng, Zhang, Peng-Fei, Huang, Xiao-Yong, Guo, Xiao-Jun, Gao, Chao, Zeng, Hai-Ying, Zheng, Yi-Min, Wang, Si-Wei, Cai, Jia-Bin, Sun, Qi-Man, Shi, Ying-Hong, Zhou, Jian, Ke, Ai-Wu, Shi, Guo-Ming, Fan, Jia
Publicado 2021

Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma

por Liu, Li-Xin, Lu, Jia-Cheng, Zeng, Hai-Ying, Cai, Jia-Bin, Zhang, Peng-Fei, Guo, Xiao-Jun, Huang, Xiao-Yong, Dong, Rui-Zhao, Zhang, Chi, Kang, Qiang, Zou, Hao, Zhang, Xin-Yu, Zhang, Lu, Zhang, Xiao-Wen, Ke, Ai-Wu, Shi, Guo-Ming
Publicado 2019

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis

por Guo, Xiao-Jun, Huang, Xiao-Yong, Yang, Xuan, Lu, Jia-Cheng, Wei, Chuan-Yuan, Gao, Chao, Pei, Yan-Zi, Chen, Yi, Sun, Qi-Man, Cai, Jia-Bin, Zhou, Jian, Fan, Jia, Ke, Ai-Wu, Shi, Yujiang G., Shen, Ying-Hao, Zhang, Peng-Fei, Shi, Guo-Ming, Yang, Guo-Huan
Publicado 2023

Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma

por Xie, Nan, Cai, Jia-Bin, Zhang, Lu, Zhang, Peng-Fei, Shen, Ying-Hao, Yang, Xuan, Lu, Jia-Cheng, Gao, Dong-Mei, Kang, Qiang, Liu, Li-Xin, Zhang, Chi, Huang, Xiao-Yong, Zou, Hao, Zhang, Xin-Yu, Song, Zheng-Ji, Sun, Hai-Xiang, Fu, Bi-Mang, Ke, Ai-Wu, Shi, Guo-Ming
Publicado 2017

Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC

por Ke, Ai-Wu, Zhang, Peng-Fei, Shen, Ying-Hao, Gao, Ping-Ting, Dong, Zhao-Ru, Zhang, Chi, Cai, Jia-Bin, Huang, Xiao-Yong, Wu, Chao, Zhang, Lu, Kang, Qiang, Liu, Li-Xin, Xie, Nan, Shen, Zao-Zhuo, Hu, Mei-Yu, Cao, Ya, Qiu, Shuang-Jian, Sun, Hui-Chuan, Zhou, Jian, Fan, Jia, Shi, Guo-Ming
Publicado 2016